期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

耐多药结核病诊断与治疗新进展 被引量：5

原文传递
导出
摘要 耐多药结核病（multidrug-resistant tuberculosis，MDR-TB）的流行与传播使本已严峻的全球结核病防治形势变得更加紧迫，也引起了各国结核病防治工作者的极大关注和不安。MDR-TB的发生与发展暴露了世界结核病控制措施的薄弱和不足，也给全球公共卫生带来了前所未有的挑战。
作者 曹咏红 曹子中 李勇
机构地区 广西龙潭医院结核科
出处 《中国医师进修杂志》 2010年第12期70-71,78,共3页 Chinese Journal of Postgraduates of Medicine
基金 国家科技重大专项课题（2008ZX10003-015）
关键词 结核病诊断 耐多药结核病 TUBERCULOSIS 治疗 MDR-TB 公共卫生 工作者 控制措
分类号 R52 [医药卫生—内科学]
  • 相关文献

参考文献13

  • 1Espinal M, Raviglione MC. From threat to reality:the real face of multidrug-resistant tuberculosis. Am J Respir Crit Care Med, 2008,178(3):216-217.
  • 2唐神结,肖和平,张青.耐多药结核病化疗研究的新进展[J].中华结核和呼吸杂志,2009,32(8):617-620. 被引量：32
  • 3Center for Disease Control and Prevention (CDC). Extensively drug-resistant tuberculosis -United States, 1993-2006. MMWR Morb Mortal Wkly Rep, 2007,56( 11 ) : 250-253.
  • 4Gandhi NR,Moll A,Sturm AW,et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.Lancet, 2006,368(9547 ) : 1575-1580.
  • 5肖和平.耐药肺结核化学治疗指南.北京:中国防痨协会,2009.
  • 6Kim SJ. Drug-susceptibility testing in tuberculosis: methods and reliability of results. Eur Respir J, 2005,25 (3): 564-569.
  • 7World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis:emergency update 2008. Geneva: World Health Organization,2008.
  • 8Global Alliance for TB Drug Development. Handbook of anti-tuberculosis agents. Tuberculosis(Edinb), 2008,88 (2): 85-86.
  • 9Moadebi S, Harder CK,Fitzgerald MJ,et al. Fluoroquinolones for the treatment of pulmonary tuberculosis. Drugs,2007,67 (14): 2077-2099.
  • 10Masjedi MR, Tabarsi P, Chitsaz E ,et al. Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002-2006.Int J Tuberc Lung Dis,2008,12(7): 750-755.

二级参考文献39

  • 1祝斌,潘金凤,吴征斌,李春红,刘银开,林志新,曹敬银,朱友生.活动性结核标志物(ATM)快速诊断结核的研究[J].临床肺科杂志,2004,9(5):542-543. 被引量：6
  • 2李德宪,吕江清,邝浩斌,陈志宏,何刚.联合检测结素试验和血清抗结核抗体对成人肺结核诊断预测价值:Bayesian分析[J].中国防痨杂志,2005,27(1):8-12. 被引量：17
  • 3Aziz MA, Wright A, Laszlo A, et al. Epidemiology of antituberculosis drug resistance (the Global Project on Antituberculosis Drug Resistance Surveillance) : an updated analysis. Lancet, 2006,368: 2142-2154.
  • 4Espinal M, Raviglione MC. From threat to reality: the real face of muhidrug-resistant tuberculosis. Am J Respir Crit Care Med, 2008,178:216-217.
  • 5Center for Disease Control and Prevention (CDC). Extensively drug-resistant tuberculosis--United States, 1993-2006. MMWR Morb Mortal Wkly Rep, 2007,56:250-253.
  • 6Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet, 2006,368 : 1575-1580.
  • 7Masjedi MR, Tabarsi P, Chitsaz E, et al. Outcome of treatment of MDR-TB patients with standardised regimens,Iran,2002-2006. Int J Tuberc Lung Dis, 2008,12:750-755.
  • 8Leimane V, Riekstina V, Holtz TH, et al. Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia : a retrospective cohort study. Lancet, 2005,365:318-326.
  • 9World Health Organization. Stop TB partnership and world health organization. Global plan to stop TB 2006-2015. Geneva: WHO, 2006.
  • 10World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis: emergency update 2008. Geneva: WHO, 2008.

共引文献33

同被引文献61

引证文献5

二级引证文献17

中国医师进修杂志
2010年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部